DISEASE SCANNER
Global Incurable Diseases Tracker
Chikungunya
A mosquito-borne viral disease transmitted by Aedes aegypti and Aedes albopictus mosquitoes. Causes sudden onset fever and severe joint pain. First identified in Tanzania in 1952. Name means 'that which bends up' describing the stooped posture from joint pain.
2.0M
92
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1RT-PCR (first week)
- 2Serology (IgM/IgG ELISA)
- 3Viral culture
- 4Clinical diagnosis in outbreaks
Prognosis
Usually self-limiting (1-2 weeks). 30-40% develop chronic arthralgia lasting months to years. Rarely fatal. Immunity after infection believed lifelong.
Prevention
- Mosquito bite prevention
- DEET repellents
- Protective clothing
- Eliminating standing water
- IXCHIQ vaccine (newly approved)
- Air conditioning/screens
Research Status
No specific antiviral or vaccine currently available. Live-attenuated vaccine (IXCHIQ) FDA-approved December 2023. Supportive care mainstay. Research into persistent arthralgia mechanisms. Vector control remains primary prevention.
Affected Countries
Sources
- https://www.cdc.gov
- https://www.who.int
- https://www.hematology.org/education/patients
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.